Masimo Corporation (MASI)

Market Cap	8.80B
Revenue (ttm)	2.13B
Net Income (ttm)	-494.50M
Shares Out	54.22M
EPS (ttm)	-9.23
PE Ratio	n/a
Forward PE	32.89
Dividend	n/a
Ex-Dividend Date	n/a

Volume	105,795
Open	165.75
Previous Close	166.32
Day's Range	161.03 - 165.75
52-Week Range	101.61 - 194.88
Beta	1.19
Analysts	Buy
Price Target	187.00 (+15.27%)
Earnings Date	Aug 5, 2025

About MASI

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arter...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 8, 2007
• Employees: 3,600
• Stock Exchange: NASDAQ
• Ticker Symbol: MASI
• Website: https://www.masimo.com

Analyst Summary

According to 6 analysts, the average rating for MASI stock is "Buy." The 12-month stock price target is $187.0, which is an increase of 15.27% from the latest price.

Price Target

$187.0

(15.27% upside)

Analyst Consensus: Buy